These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1347499)

  • 1. Neuropsychological test scores and clinical response to neuroleptic drugs in schizophrenic patients.
    Smith RC; Largen J; Vroulis G; Ravichandran GK
    Compr Psychiatry; 1992; 33(2):139-45. PubMed ID: 1347499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of relationship of neuroleptic dose and blood serum levels to neuropsychological performance on the LNNB in chronic schizophrenia.
    Puente AE; Tune L
    Int J Neurosci; 1996 Oct; 87(1-2):107-10. PubMed ID: 8913825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological deficits in chronic schizophrenics. Relationship with symptoms and behavior.
    Dickerson FB; Ringel NB; Boronow JJ
    J Nerv Ment Dis; 1991 Dec; 179(12):744-9. PubMed ID: 1744633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological differentiation of chronic schizophrenia.
    Puente AE; Rodenbough J; Orrell TD
    Int J Neurosci; 1993 Oct; 72(3-4):193-200. PubMed ID: 7908012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luria-Nebraska performance and symptomatology in unmedicated schizophrenic patients.
    Faustman WO; Moses JA; Csernansky JG
    Psychiatry Res; 1988 Oct; 26(1):29-34. PubMed ID: 3237904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between medication treatments and neuropsychological test performance in schizophrenia.
    Sweeney JA; Keilp JG; Haas GL; Hill J; Weiden PJ
    Psychiatry Res; 1991 Jun; 37(3):297-308. PubMed ID: 1679950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological performance in chronic schizophrenia in response to neuroleptic dose reduction.
    Seidman LJ; Pepple JR; Faraone SV; Kremen WS; Green AI; Brown WA; Tsuang MT
    Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):575-84. PubMed ID: 8101100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attentional dysfunctions in neuroleptic-naive and neuroleptic-withdrawn schizophrenic patients and their siblings.
    Finkelstein JR; Cannon TD; Gur RE; Gur RC; Moberg P
    J Abnorm Psychol; 1997 May; 106(2):203-12. PubMed ID: 9131840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic drug effects on cognitive function in schizophrenia.
    Cleghorn JM; Kaplan RD; Szechtman B; Szechtman H; Brown GM
    Schizophr Res; 1990; 3(3):211-9. PubMed ID: 1980613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological dysfunction in schizophrenia. Relation to associative thought disorder.
    Silverstein ML; Arzt AT
    J Nerv Ment Dis; 1985 Jun; 173(6):341-6. PubMed ID: 3998719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term cognitive improvement in schizophrenics treated with typical and atypical neuroleptics.
    Rollnik JD; Borsutzky M; Huber TJ; Mogk H; Seifert J; Emrich HM; Schneider U
    Neuropsychobiology; 2002; 45(2):74-80. PubMed ID: 11893863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.
    Bilder RM; Goldman RS; Robinson D; Reiter G; Bell L; Bates JA; Pappadopulos E; Willson DF; Alvir JM; Woerner MG; Geisler S; Kane JM; Lieberman JA
    Am J Psychiatry; 2000 Apr; 157(4):549-59. PubMed ID: 10739413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic dose reduction in older psychotic patients.
    Harris MJ; Heaton RK; Schalz A; Bailey A; Patterson TL
    Schizophr Res; 1997 Oct; 27(2-3):241-8. PubMed ID: 9416653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia.
    Saykin AJ; Shtasel DL; Gur RE; Kester DB; Mozley LH; Stafiniak P; Gur RC
    Arch Gen Psychiatry; 1994 Feb; 51(2):124-31. PubMed ID: 7905258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insight in schizophrenia. Its relationship to acute psychopathology.
    McEvoy JP; Apperson LJ; Appelbaum PS; Ortlip P; Brecosky J; Hammill K; Geller JL; Roth L
    J Nerv Ment Dis; 1989 Jan; 177(1):43-7. PubMed ID: 2562850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of brain-damage in schizophrenics as measured by the Whitaker Index of Schizophrenic Thinking and the Luria-Nebraska Neuropsychological Battery.
    Puente AE; Heidelberg-Sanders C; Lund N
    Percept Mot Skills; 1982 Apr; 54(2):495-9. PubMed ID: 7079075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential rate of neuropsychological dysfunction in psychiatric disorders: comparison between the Halstead-Reitan and Luria-Nebraska batteries.
    Bryson GJ; Silverstein ML; Nathan A; Stephen L
    Percept Mot Skills; 1993 Feb; 76(1):305-6. PubMed ID: 8451141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral ventricular size and neuropsychological impairment in young chronic schizophrenics. Measurement by the standardized Luria-Nebraska Neuropsychological Battery.
    Golden CJ; Moses JA; Zelazowski R; Graber B; Zatz LM; Horvath TB; Berger PA
    Arch Gen Psychiatry; 1980 Jun; 37(6):619-23. PubMed ID: 6966917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Validation of the Luria-Nebraska neuropsychological battery (Spanish version)].
    Hernández E; Boget T; Marcos T
    Ann Med Psychol (Paris); 1988; 146(1-2):124-9. PubMed ID: 3415119
    [No Abstract]   [Full Text] [Related]  

  • 20. A study of the pharmacologic treatment of medication-compliant schizophrenics who relapse.
    Steingard S; Allen M; Schooler NR
    J Clin Psychiatry; 1994 Nov; 55(11):470-2. PubMed ID: 7989278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.